Pear Therapeutics Raises $50 Million To Develop & Market A Portfolio Of Digital Therapeutics For Mental Health

Pear Therapeutics recently raised $50 million to go toward the development and marketing of a portfolio of digital therapeutics for mental health. The funding was led by Temasek in collaboration with 5AM Ventures, Arboretum ventures, and JAZZ Venture Partners, amongst others.

Company leadership has stated that the majority of the funding will be going towards commercializing reSET and reSET-O, it’s treatments for addiction disorder and opioid use disorder. Additionally, Pear Therapeutics wants to put some of the funding towards advancing its pipeline to bring more prescription digital therapeutics to consumers for various diseases.

Pear Therapeutics operates primarily in . . .